BURRELL INTERNATIONAL GROUP LLC

Lobbying for CELLPHIRE, INC. · Biotechnology Company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $40,000.00 income · posted Jan 14, 2026

Lobbying activity 1

Health Issues

Pandemic and All Hazard Preparedness Act, FY26 LHHS and Defense Appropriations for next generation blood products; FY26 NDAA, FY26 LHHS and FY26 DoD Authorization and Appropriations for Freeze-dried platelet and next gen blood products

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.